STAT STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We dissect crucial discoveries.

We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and me...
07/25/2025

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.

Doximity offers a free ambient scribe physicians, nurse practitioners, physician assistants, and med students.
07/25/2025

Doximity offers a free ambient scribe physicians, nurse practitioners, physician assistants, and med students.

Doximity offers a free ambient scribe for physicians, nurse practitioners, physician assistants, and med students.

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the...
07/24/2025

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the approach lacks sufficient evidence to be expanded.

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the approach lacks sufficient evidence to be expanded.

UnitedHealth confirms DOJ investigations into Medicare practices, and says it’s cooperating.
07/24/2025

UnitedHealth confirms DOJ investigations into Medicare practices, and says it’s cooperating.

UnitedHealth confirms DOJ investigations into Medicare practices, and says it’s cooperating.

And more major health news stories.
07/24/2025

And more major health news stories.

And more major health news stories.

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that str...
07/24/2025

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that strengthens pandemic preparedness and protects American interests?

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that strengthens pandemic preparedness and protects American interests?

The safety of fluoride supplements, and freedom of choice, was debated at an FDA meeting this week.
07/24/2025

The safety of fluoride supplements, and freedom of choice, was debated at an FDA meeting this week.

The safety of fluoride supplements, and freedom of choice, was debated at an FDA meeting this week.

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are...
07/24/2025

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are caught in the middle.

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are caught in the middle.

This week on "The Readout LOUD" podcast, a mother whose son has Duchenne muscular dystrophy shares her perspective on Sa...
07/24/2025

This week on "The Readout LOUD" podcast, a mother whose son has Duchenne muscular dystrophy shares her perspective on Sarepta's gene therapy halt.

This week on "The Readout LOUD" podcast, a mother whose son has Duchenne muscular dystrophy shares her perspective on Sarepta's gene therapy halt.

And other biotech news brought to you by The Readout.
07/24/2025

And other biotech news brought to you by The Readout.

And other biotech news brought to you by The Readout.

Roche reported better than expected first-half operating profit, driven by strong sales of breast cancer and asthma trea...
07/24/2025

Roche reported better than expected first-half operating profit, driven by strong sales of breast cancer and asthma treatments

Roche reported better than expected first-half operating profit, driven by strong sales of breast cancer and asthma treatments

To suggest Sarepta Therapeutics may not survive its gene therapy crisis is a sobering claim to make, STAT's Adam Feuerst...
07/24/2025

To suggest Sarepta Therapeutics may not survive its gene therapy crisis is a sobering claim to make, STAT's Adam Feuerstein writes. But it's an accurate reflection of the situation.

To suggest Sarepta Therapeutics may not survive its gene therapy crisis is a sobering claim to make, STAT's Adam Feuerstein writes. But it's an accurate reflection of the situation.

Address

Boston, MA

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Alerts

Be the first to know and let us send you an email when STAT posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share